Fulgent Genetics Inc Equity-NMS: FLGT

Healthcare

Diagnostics & Research

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :

$39.75

52W high :

$65.17

1Y :

-25.79%

5Y :

912%

EPS(TTM): :

-0.8486

Shares O/S :

29.7 M

Market cap :

1.19 B

What is the share price of Fulgent Genetics Inc today?

Fulgent Genetics Inc (FLGT) share price as of June 6, 2023, is $39.75. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Fulgent Genetics Inc?

Yes, Indian Investors can invest in the Fulgent Genetics Inc (FLGT) Share by opening an international trading account with Angel One.

How can I purchase Fulgent Genetics Inc shares in India?

Purchasing Fulgent Genetics Inc (FLGT) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Fulgent Genetics Inc (FLGT) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Fulgent Genetics Inc?

Yes, you can purchase fractional shares of Fulgent Genetics Inc (FLGT) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Fulgent Genetics Inc?

The market capitalization of Fulgent Genetics Inc on June 6, 2023, is $1.19 B.

In which sector Fulgent Genetics Inc belongs?

Fulgent Genetics Inc operates in the Healthcare sector, specifically in the Diagnostics & Research industry.

What documents are required to invest in Fulgent Genetics Inc stocks?

In order to invest in Fulgent Genetics Inc (FLGT) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

Fulgent Genetics, Inc. is a technology-based company with a clinical diagnostic business and a therapeutic development business. The Company's clinical diagnostic business offers molecular diagnostic testing services, genetic testing, and anatomic pathology laboratory services designed to provide physicians and patients with clinically actionable diagnostic information. Its therapeutic development business is focused on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform designed to improve the therapeutic window and pharmacokinetic profile (PK) profile of new and existing cancer drugs. Its business is built on its technology platform, which includes gene probes, data suppression and comparison algorithms, learning software, and laboratory information management systems. The Company's technology platform offers a test menu. The Company also offers next-generation sequencing (NGS) services.